Patel Gautam (CIK 1738054) reported 10 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-08-12). Recent activity: Buy AMRX (283,632 shares), Buy AMRX (34,819 shares), Buy SPB (4,602 shares), Sell AMRX (94,906 shares), Sell AMRX (56,426 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-12 | Amneal Pharmaceuticals, Inc. (AMRX) | Director | Buy | 283,632 | $0 |
| 2026-05-08 | Amneal Pharmaceuticals, Inc. (AMRX) | Director | Buy | 34,819 | $0 |
| 2025-12-16 | Spectrum Brands Holdings, Inc. (SPB) | Director | Buy | 4,602 | $0 |
| 2025-06-18 | Amneal Pharmaceuticals, Inc. (AMRX) | Director | Sell | 94,906 | $761,146 |
| 2025-06-12 | Amneal Pharmaceuticals, Inc. (AMRX) | Director | Sell | 56,426 | $452,537 |
| 2025-05-08 | Amneal Pharmaceuticals, Inc. (AMRX) | Director | Buy | 40,258 | $0 |
| 2025-05-06 | Amneal Pharmaceuticals, Inc. (AMRX) | Director | Sell | 3,768 | $30,144 |
| 2025-05-06 | Amneal Pharmaceuticals, Inc. (AMRX) | Director | Sell | 4,900 | $39,200 |
| 2025-04-02 | Amneal Pharmaceuticals, Inc. (AMRX) | Director | Sell | 80,000 | $664,000 |
| 2025-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | Director | Sell | 80,000 | $712,000 |
Source: SEC Form 4 filings · as of 2026-08-12